# The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients

> **NCT02306239** · NA · UNKNOWN · sponsor: **Liu ZiMeng** · enrollment: 40 (estimated)

## Conditions studied

- Terlipressin
- Septic Shock

## Interventions

- **DRUG:** Terlipressin
- **DRUG:** Norepinephrine

## Key facts

- **NCT ID:** NCT02306239
- **Lead sponsor:** Liu ZiMeng
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-12
- **Primary completion:** 2015-08
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2014-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02306239

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02306239, "The Effect of Terlipressin on Intesitnal Function in Septic Shock Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02306239. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*